Insider Transactions in Q2 2023 at Pulse Biosciences, Inc. (PLSE)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Jun 14 2023	Robert W Duggan Director	BUY Exercise of in-the-money or at-the-money derivatives securities	Indirect	81,025 +14.14%	$162,050 $2.05 P/Share
Jun 14 2023	Robert W Duggan Director	BUY Exercise of in-the-money or at-the-money derivatives securities	Direct	5,683,163 +13.6%	$11,366,326 $2.05 P/Share
Jun 12 2023	Darrin Uecker Chief Technology Officer	BUY Exercise of in-the-money or at-the-money derivatives securities	Direct	7,365 +0.83%	$14,730 $2.05 P/Share
Jun 09 2023	Maky Zanganeh Director	BUY Exercise of in-the-money or at-the-money derivatives securities	Direct	86,668 +9.86%	$173,336 $2.05 P/Share
May 25 2023	Mitchell E. Levinson Chief Strategy Officer	BUY Exercise of in-the-money or at-the-money derivatives securities	Indirect	1,243 +16.34%	$2,486 $2.05 P/Share
May 25 2023	Mitchell E. Levinson Chief Strategy Officer	BUY Exercise of in-the-money or at-the-money derivatives securities	Direct	10,935 +4.52%	$21,870 $2.05 P/Share
May 09 2023	Robert W Duggan Director	BUY Open market or private purchase	Direct	10,022,937 +24.79%	$60,137,622 $6.51 P/Share

Receive a notification when an Institution or Guru buys or sells PLSE shares.

Notify only if

Value

Get notified when an Pulse Biosciences, Inc. insider buys or sells PLSE shares.

Notify only if

Operation

Value

Type

Receive news related to Pulse Biosciences, Inc.